Cargando…
Preparation, Characterization, and In Vivo Pharmacoscintigraphy Evaluation of an Intestinal Release Delivery System of Prussian Blue for Decorporation of Cesium and Thallium
BACKGROUND: Prussian blue (PB, ferric hexacyanoferrate) is approved by US-FDA for internal decorporation of Cesium-137 ((137)Cs) and Thallium-201 ((201)Tl). AIM: Since PB is a costly drug, pH-dependent oral delivery system of PB was developed using calcium alginate matrix system. METHODS: Alginate (...
Autores principales: | Sandal, Nidhi, Mittal, Gaurav, Bhatnagar, Aseem, Pathak, Dharam Pal, Singh, Ajay Kumar |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5727830/ https://www.ncbi.nlm.nih.gov/pubmed/29318045 http://dx.doi.org/10.1155/2017/4875784 |
Ejemplares similares
-
A Prussian blue analog as a decorporation agent for the simultaneous removal of cesium and reactive oxygen species
por: Xue, Tingyu, et al.
Publicado: (2023) -
Porous 3D Prussian blue/cellulose aerogel as a decorporation agent for removal of ingested cesium from the gastrointestinal tract
por: Lee, Ilsong, et al.
Publicado: (2018) -
Removal of Radioactive Cesium Using Prussian Blue Magnetic Nanoparticles
por: Jang, Sung-Chan, et al.
Publicado: (2014) -
Thallium Labeled Citrate-Coated Prussian Blue Nanoparticles as Potential Imaging Agent
por: Szigeti, Krisztián, et al.
Publicado: (2018) -
Mechanochemically Synthesized Prussian Blue for Efficient
Removal of Cesium Ions from Aqueous Solutions
por: Lee, Ji Hwan, et al.
Publicado: (2022)